Tenders/1-IMMU01-KIOVIG - GAMMAGARD - HYQVIA

1-IMMU01-KIOVIG - GAMMAGARD - HYQVIA

Consorci Corporació Sanitària Parc Taulí de Sabadell

Published: Oct 12, 2026

Updated: Oct 12, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Spain, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, originating from Spain and sourced via TED, pertains to the procurement of specific pharmaceutical products: "1-IMMU01-KIOVIG - GAMMAGARD - HYQVIA". These are all brand names for immunoglobulin therapies, typically used to treat primary and secondary immunodeficiencies. The contracting authority is seeking to purchase these high-value biological medicines. This is a specialized procurement within the healthcare sector. Requirements for such tenders usually include the bidder being an authorized distributor or the manufacturer of the specified medications, adherence to strict pharmaceutical regulations regarding storage, handling, and distribution, and the ability to supply consistent and reliable quantities. The tender documentation will detail the exact products, required dosages or presentations, estimated quantities, delivery schedules, and specific contractual terms related to pharmaceutical supply chain integrity and patient safety. The successful bidder will play a crucial role in ensuring patient access to essential immunotherapies.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 12, 2026. Last refreshed today. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Consorci Corporació Sanitària Parc Taulí de Sabadell

Consorci Corporació Sanitària Parc Taulí de Sabadell has issued 84 procurement notices on BidsFactory, including 13 currently open and 59 awarded contracts. Activity concentrates in Health & Medical, Finance & Banking, and Information & Communication Technology. All notices are published for Spain. Notices are distributed via PLACSP - Plataforma de Contratación del Sector Público and TED - Tenders Electronic Daily (EU). Most recent publication: October 9, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Spain. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Consorci Corporació Sanitària Parc Taulí de Sabadell in Spain. The authority is responsible for evaluating bids, awarding the contract, and managing performance.